Danaher Corp (NYSE:DHR)
| 182.88 BATS BZX Real-Time Price As of 2:24pm ET |  -0.12 / -0.07%Today’s Change | 119.60 Today|||52-Week Range 184.69 | +19.16% Year-to-Date |
Latest DHR News | Press Releases
| These 3 Stocks Are Potential Buyout Targets Jul 03 / MotleyFool.com - Paid Partner Content | Is It Time to Cash In on Meridian Bioscience? Jun 24 / MotleyFool.com - Paid Partner Content |
| Ignore General Electric: Here Are 3 Better Stocks Jun 26 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 183.00 |
| Today’s open | 182.94 |
| Day’s range | 182.08 - 184.69 |
| Volume | 1,859,294 |
| Average volume (3 months) | 3,733,684 |
| Market cap | $127.2B |
Data as of 2:24pm ET, 07/07/2020
Growth & Valuation
| Earnings growth (last year) | -7.92% |
| Earnings growth (this year) | +12.59% |
| Earnings growth (next 5 years) | +6.09% |
| Revenue growth (last year) | -9.96% |
| P/E ratio | 50.6 |
| Price/Sales | 6.22 |
| Price/Book | 4.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TMOThermo Fisher Scient... | +0.20 | +0.05% |
| AAgilent Technologies... | -0.02 | -0.02% |
| MTDMettler-Toledo Inter... | -2.68 | -0.33% |
| BIOBio Rad Laboratories... | +7.15 | +1.54% |
Data as of 2:24pm ET, 07/07/2020
Financials
| Next reporting date | July 16, 2020 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $17.9B |
| Annual profit (last year) | $2.6B |
| Net profit margin | 13.58% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Washington, District Of Columbia |
Forecasts
